maprotiline has been researched along with Serotonin Syndrome in 1 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Serotonin Syndrome: An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertolín-Guillén, JM | 1 |
| Climent-Díaz, B | 1 |
| Navarré-Gimeno, A | 1 |
1 other study available for maprotiline and Serotonin Syndrome
| Article | Year |
|---|---|
Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine.
Topics: Cyclohexanols; Depressive Disorder; Emergency Medical Services; Humans; Male; Maprotiline; Middle Ag | 2004 |